Search all medical codes

Prolymphocytic leukemia of T-cell type, in relapse

ICD10CM code

Medical Policies and Guidelines for Prolymphocytic leukemia of T-cell type, in relapse

Related policies from health plans

Izervay (avacincaptad pegol)

Similar Codes


ICD10CM codes

C91.62 - Prolymphocytic leukemia of T-cell type, in relapse
C91.32 - Prolymphocytic leukemia of B-cell type, in relapse
C91.61 - Prolymphocytic leukemia of T-cell type, in remission
C91.92 - Lymphoid leukemia, unspecified, in relapse
C91.31 - Prolymphocytic leukemia of B-cell type, in remission
C91.12 - Chronic lymphocytic leukemia of B-cell type in relapse
C91.02 - Acute lymphoblastic leukemia, in relapse
C91.6 - Prolymphocytic leukemia of T-cell type
C91.Z2 - Other lymphoid leukemia, in relapse
C90.12 - Plasma cell leukemia in relapse

HCPCS codes

G9842 - Patient has metastatic disease at diagnosis
G9396 - Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve m
Q2043 - Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leuk
J9311 - Injection, rituximab 10 mg and hyaluronidase
G9097 - Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as
Q2041 - Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, includi
G9223 - Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below
C9467 - Injection, rituximab and hyaluronidase, 10 mg
P9058 - Red blood cells, leukocytes reduced, cmv-negative, irradiated, each unit
J9312 - Injection, rituximab, 10 mg

CPT4 codes

88230 - Tissue culture for non-neoplastic disorders; lymphocyte
38242 - Allogeneic lymphocyte infusions
3092F - Major depressive disorder, in remission (MDD)
96406 - Chemotherapy administration; intralesional, more than 7 lesions
81340 - TRB@ (T cell antigen receptor, beta) (eg, leukemia and lymphoma), gene rearrangement analysis to det
81342 - TRG@ (T cell antigen receptor, gamma) (eg, leukemia and lymphoma), gene rearrangement analysis, eval
81305 - MYD88 (myeloid differentiation primary response 88) (eg, Waldenstrom's macroglobulinemia, lymphoplas
81315 - PML/RARalpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (eg, promyelocytic l
81339 - MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; s
88237 - Tissue culture for neoplastic disorders; bone marrow, blood cells